The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Open accessAbstract
BACKGROUND: In 2002, we reported the initial results of a trial comparing radical prostatectomy with watchful waiting in the management of early prostate cancer. After three more years of follow-up, we report estimated 10-year results. METHODS: From October 1989 through February 1999, 695 men with early prostate cancer (mean age, 64.7 years) were randomly assigned to radical prostatectomy (347 men) or watchful waiting (348 men). The follow-up was complete through 2003, with blinded evaluation of the causes of death. The primary end point was death due to prostate cancer; the secondary end points were death from any cause, metastasis, and local progression. RESULTS: During a median of 8.2 years of follow-up, 83 men in the surgery group and 106 men in the watchful-waiting group died (P=0.04). In 30 of the 347 men assigned to surgery (8.6 percent) and 50 of the 348 men assigned to watchful waiting (14.4 percent), death was due to prostate cancer. The difference in the cumulative incidence of death due to prostate cancer increased from 2.0 percentage points after 5 years to 5.3 percentage points after 10 years, for a relative risk of 0.56 (95 percent confidence interval, 0.36 to 0.88; P=0.01 by Gray's test). For distant metastasis, the corresponding increase was from 1.7 to 10.2 percentage points, for a relative risk in the surgery group of 0.60 (95 percent confidence interval, 0.42 to 0.86; P=0.004 by Gray's test), and for local progression, the increase was from 19.1 to 25.1 percentage points, for a relative risk of 0.33 (95 percent confidence interval, 0.25 to 0.44; P<0.001 by Gray's test). CONCLUSIONS: Radical prostatectomy reduces disease-specific mortality, overall mortality, and the risks of metastasis and local progression. The absolute reduction in the risk of death after 10 years is small, but the reductions in the risks of metastasis and local tumor progression are substantial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One of the “gold standard” treatments for early stage prostate cancer is radical prostatectomy (RP), which has established long-term benefit (2-5).”
From Men's experience with penile rehabilitation following radical prostatectomy: a qualitative study with the goal of informing a therapeutic intervention. (2015) · cites this paper as [2]
Citations
Cites
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Results of Conservative Management of Clinically Localized Prostate Cancer
Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J.-E., Adolfsson, J., Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M., & Warner, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300403 · Cited by 928
Self-citationA Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
Holmberg, L., Bill-Axelson, A., Helgesen, F., Salo, J. O., Folmerz, P., Häggman, M., Andersson, S.-O., Spångberg, A., Busch, C., Nordling, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012794 · Cited by 817
Self-citationQuality of Life after Radical Prostatectomy or Watchful Waiting
Steineck, G., Helgesen, F., Adolfsson, J., Dickman, P. W., Johansson, J.-E., Norlén, B. J., & Holmberg, L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021483 · Cited by 722
Self-citationNatural History of Early, Localized Prostate Cancer
Johansson, J.-E. (2004) · JAMA · doi:10.1001/jama.291.22.2713 · Cited by 703
Self-citationPotosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680
The role of radical prostatectomy in the management of prostatic cancer
Walsh, P. C., & Lepor, H. (1987) · Cancer · doi:10.1002/1097-0142(19870801)60:3+<526::aid-cncr2820601515>3.0.co;2-9 · Cited by 131
Carcinoma of the prostate. Hormonal therapy
Grayhack, J. T., Keeler, T. C., & Kozlowski, J. M. (1987) · Cancer · doi:10.1002/1097-0142(19870801)60:3+<589::aid-cncr2820601526>3.0.co;2-r · Cited by 111
Staging Pelvic Lymphadenectomy for Carcinoma of the Prostate: Risk Versus Benefit
Brendler, C. B., Cleeve, L. K., Anderson, E. E., & Paulson, D. F. (1980) · The Journal of Urology · doi:10.1016/s0022-5347(17)55696-7 · Cited by 106
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden
Johansson, J.-E. (1997) · JAMA · doi:10.1001/jama.277.6.467 · Cited by 102
Self-citation
Research works printed but not linked: 1
- 10.1002/1097-0142(19930715)72:2<310::AID-CNCR2820720203>3.0.CO;2-T · doi:10.1002/1097-0142(19930715)72:2<310::aid-cncr2820720203>3.0.co;2-t
Cited by
Items 201–300 of 999
Lee, M., Dong, F., Stephenson, A. J., Jones, J. S., Magi‐Galluzzi, C., & Klein, E. A. (2009) · European Urology · doi:10.1016/j.eururo.2009.10.025 · Cited by 73
Mikhail, D., Sarcona, J., Mekhail, M., & Richstone, L. (2020) · Surgical Clinics of North America · doi:10.1016/j.suc.2019.12.003 · Cited by 73
Orgasm-Associated Urinary Incontinence and Sexual Life After Radical Prostatectomy
Nilsson, A. E., Carlsson, S., Johansson, E., Jonsson, M. N., Adding, C., Nyberg, T., Steineck, G., & Wiklund, P. N. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02347.x · Cited by 74
Abdollah, F., Sun, M., Schmitges, J., Tian, Z., Claudio Jeldres, A., Briganti, A., Shariat, S. F., Perrotte, P., Montorsi, F., & Karakiewicz, P. I. (2011) · European Urology · doi:10.1016/j.eururo.2011.06.039 · Cited by 73
The 100 most-cited articles in urological surgery: A bibliometric analysis
He, L., Fang, H., Wang, X., Wang, Y., Ge, H., Li, C., Chen, C., Wan, Y., & He, H. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2019.12.030 · Cited by 72
Nomogram use for the prediction of indolent prostate cancer
Roemeling, S., Roobol, M. J., Kattan, M. W., van der Kwast, T., Steyerberg, E. W., & Schröder, F. H. (2007) · Cancer · doi:10.1002/cncr.23029 · Cited by 71
Akaza, H., Homma, Y., Usami, M., Hirao, Y., Tsushima, T., Okada, K., Yokoyama, M., Ohashi, Y., Aso, Y., & THE PROSTATE CANCER STUDY GROUP (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06349.x · Cited by 71
Aron, M., Kaouk, J. H., Hegarty, N. J., Colombo, J. R., Haber, G., Chung, B. I., Zhou, M. S., & Gill, I. S. (2007) · Journal of Endourology · doi:10.1089/end.2006.9938 · Cited by 71
Prostate mechanical imaging: 3-D image composition and feature calculations
Egorov, V., Ayrapetyan, S., & Sarvazyan, A. P. (2006) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2006.880667 · Cited by 69
Lu‐Yao, G. L., Albertsen, P. C., Moore, D. F., Lin, Y., DiPaola, R. S., & Yao, S. (2015) · European Urology · doi:10.1016/j.eururo.2015.03.021 · Cited by 71
Sun, M., Sammon, J. D., Becker, A., Roghmann, F., Tian, Z., Kim, S. P., Larouche, A., Abdollah, F., Hu, J. C., Karakiewicz, P. I., et al. (2013) · British Journal of Urology · doi:10.1111/bju.12321 · Cited by 70
on behalf of the Trans-Atlantic Prostate Group, Foster, C. S., Dodson, A. R., Ambroisine, L., Fisher, G., Møller, H., Clark, J., Attard, G., Bono, J. S. D., Scardino, P. T., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605227 · Cited by 70
Deregulation of a Hox Protein Regulatory Network Spanning Prostate Cancer Initiation and Progression
Chen, J. L., Li, J., Kiriluk, K. J., Rosen, A. M., Paner, G. P., Antic, T., Lussier, Y. A., & Griend, D. J. V. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0373 · Cited by 72
CT Screening for Lung Cancer: Update 2007
Henschke, C. I., & Yankelevitz, D. F. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0153 · Cited by 70
Expectant management for men with early stage prostate cancer
Filson, C. P., Marks, L. S., & Litwin, M. S. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21278 · Cited by 83
van Tol‐Geerdink, J. J., Leer, J. W. H., Weijerman, P. C., van Oort, I. M., VERGUNST, H., van Lin, E. N., Witjes, J. A., & Stalmeier, P. F. M. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11402.x · Cited by 71
Active surveillance for prostate cancer: trials and tribulations
Klotz, L. H. (2008) · World Journal of Urology · doi:10.1007/s00345-008-0330-8 · Cited by 69
A nomogram for predicting low‐volume/low‐grade prostate cancer
Nakanishi, H., Wang, X., Ochiai, A., Trpkov, K., Yilmaz, A., Donnelly, J. B., Davis, J. W., Troncoso, P., & Babaian, R. J. (2007) · Cancer · doi:10.1002/cncr.23055 · Cited by 69
Active surveillance versus radical treatment for favorable-risk localized prostate cancer
Klotz, L. H. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0003-z · Cited by 69
Dong, F., Kattan, M. W., Steyerberg, E. W., Jones, J. S., Stephenson, A. J., Schröder, F. H., & Klein, E. A. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.03.053 · Cited by 69
Tward, J. D., Lee, C. M., Pappas, L. M., Szabó, A., Gaffney, D. K., & Shrieve, D. C. (2006) · Cancer · doi:10.1002/cncr.22261 · Cited by 67
Prostate cancer screening: Canadian guidelines 2011
Izawa, J. I., Klotz, L. H., Siemens, D. R., Kassouf, W., So, A., Jordan, J., CHETNER, M. P., & Iansavitchene, A. (2011) · Canadian Urological Association Journal · doi:10.5489/cuaj.11134 · Cited by 65
Flaig, T., Su, L.-J., Harrison, G., Agarwal, R., & Glodé, L. (2007) · International Journal of Cancer · doi:10.1002/ijc.22465 · Cited by 72
Giuliano, F., Amar, E., Chevallier, D., Montaigne, O., Joubert, J.-M., & Chartier-Kastler, E. J. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00670.x · Cited by 64
Hakone, A., Harrison, L., Ottley, A., Winters, N. D., Gutheil, C. M., Han, P. K. J., & Chang, R. (2016) · IEEE Transactions on Visualization and Computer Graphics · doi:10.1109/tvcg.2016.2598588 · Cited by 64
Robot-Assisted Radical Prostatectomy: 5-Year Oncological and Biochemical Outcomes
Liss, M. A., Lusch, A., Morales, B., Beheshti, N., Skarecky, D. W., Narula, N., Osann, K., & Ahlering, T. E. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.08.009 · Cited by 63
Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975–2004
Hussain, S., Gunnell, D., Donovan, J., McPhail, S., Hamdy, F. C., Neal, D. E., Albertsen, P. C., Verne, J., Stephens, P. J., Trotter, C. L., et al. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07338.x · Cited by 62
van Leeuwen, P. J., Connolly, D., Gavin, A., Roobol, M. J., Black, A., Bangma, C. H., & Schröder, F. H. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.09.008 · Cited by 63
Patient acceptance of active surveillance as a treatment option for low‐risk prostate cancer
Davison, B. J., & Goldenberg, S. L. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10200.x · Cited by 62
Quality of Life for Men With Prostate Cancer
Katz, A. (2007) · Cancer Nursing · doi:10.1097/01.ncc.0000281726.87490.f2 · Cited by 61
The PSA Era is not Over for Prostate Cancer
Catàlona, W. J., & Loeb, S. (2005) · European Urology · doi:10.1016/j.eururo.2005.07.014 · Cited by 62
Health‐related quality of life in men with localized prostate cancer
Namiki, S., & Arai, Y. (2009) · International Journal of Urology · doi:10.1111/j.1442-2042.2009.02437.x · Cited by 62
Park, J. J., Kim, C. K., Park, S. Y., Park, B. K., Lee, H. M., & Cho, S. W. (2014) · American Journal of Roentgenology · doi:10.2214/ajr.13.11381 · Cited by 60
Variations Among Experienced Surgeons in Cancer Control After Open Radical Prostatectomy
Bianco, F. J., Vickers, A. J., Cronin, A. M., Klein, E. A., Eastham, J. A., Pontes, J. E., & Scardino, P. T. (2010) · The Journal of Urology · doi:10.1016/j.juro.2009.11.015 · Cited by 60
Radiation Treatment in Older Patients: A Framework for Clinical Decision Making
Smith, G. L., & Smith, B. D. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.1168 · Cited by 60
Staging Saturation Biopsy in Patients with Prostate Cancer on Active Surveillance Protocol
Abouassaly, R., Lane, B. R., & Jones, J. S. (2008) · Urology · doi:10.1016/j.urology.2007.11.094 · Cited by 59
Lawrence, E. M., Gallagher, F. A., Barrett, T., Warren, A. Y., Priest, A. N., Goldman, D. A., Sala, E., & Gnanapragasam, V. J. (2014) · American Journal of Roentgenology · doi:10.2214/ajr.13.11754 · Cited by 58
Hammarsten, P., Karalija, A., Josefsson, A., Rudolfsson, S. H., Wikström, P., Egevad, L., Granfors, T., Stattin, P. E., & Bergh, A. R. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0103 · Cited by 58
L’épidémiologie des cancers en France en 2010 : comparaison avec les États-Unis
Guérin, S., & Hill, C. (2010) · Bulletin du Cancer · doi:10.1684/bdc.2010.1013 · Cited by 72
PSA-based Screening for Prostate Cancer: How Does It Compare with Other Cancer Screening Tests?
Crawford, E. D., & Abrahamsson, P. (2008) · European Urology · doi:10.1016/j.eururo.2008.05.032 · Cited by 61
Should We Replace the Gleason Score with the Amount of High-Grade Prostate Cancer?
Vis, A. N., Roemeling, S., Ries Kranse, C., Schröder, F. H., & van der Kwast, T. (2006) · European Urology · doi:10.1016/j.eururo.2006.07.051 · Cited by 57
The Role of Primary Androgen Deprivation Therapy in Localized Prostate Cancer
Wong, Y., Freedland, S. J., Egleston, B. L., Vapiwala, N., Uzzo, R. G., & Armstrong, K. (2009) · European Urology · doi:10.1016/j.eururo.2009.03.066 · Cited by 57
Radical prostatectomy versus deferred treatment for localised prostate cancer
Vernooij, R. W. M., Lancee, M., Cleves, A., Dahm, P., Bangma, C. H., & Aben, K. K. H. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006590.pub3 · Cited by 60
Agent Orange as a risk factor for high‐grade prostate cancer
Ansbaugh, N. J., Shannon, J., Mori, M., Farris, P. E., & Garzotto, M. G. (2013) · Cancer · doi:10.1002/cncr.27941 · Cited by 56
Antiandrogen treatments in locally advanced prostate cancer: are they all the same?
Gillatt, D. A. (2006) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-006-0133-5 · Cited by 63
Mortality at 120 days after prostatic biopsy: A population‐based study of 22,175 men
Andrea Gallina, A., Suardi, N. R., Montorsi, F., Umberto Capitanio, A., Claudio Jeldres, A., Fred Saad, C., Graefen, M., Shariat, S. F., Widmer, H., Arjane, P., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23559 · Cited by 54
Holze, S., Mende, M., Healy, K. V., Köhler, N., Gansera, L., Truß, M. C., Rebmann, U., Degener, S., & Stolzenburg, J. (2019) · BMC Urology · doi:10.1186/s12894-019-0500-6 · Cited by 55
Watchful waiting and active surveillance: the current position
Adolfsson, J. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07585.x · Cited by 55
Parker, W. R., Wang, R., He, C., & Wood, D. P. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09579.x · Cited by 55
MAGE-C2/CT10 Protein Expression Is an Independent Predictor of Recurrence in Prostate Cancer
von Boehmer, L., Keller, L. S., Mortezavi, A., Provenzano, M., Sais, G., Hermanns, T., Sulser, T., Jungbluth, A. A., Old, L. J., Kristiansen, G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021366 · Cited by 54
Crawford, E. D., Black, L. K., Eaddy, M. T., & Kruep, E. J. (2010) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2009.63 · Cited by 54
Prostate cryotherapy: current status
Ritch, C. R., & Katz, A. E. (2009) · Current Opinion in Urology · doi:10.1097/mou.0b013e32831e16ce · Cited by 53
Personalized Prediction of Tumor Response and Cancer Progression on Prostate Needle Biopsy
Donovan, M. J., Khan, F. M., Fernández, G., Mesa‐Tejada, R., Sapir, M., Zubek, V. B., Powell, D., Fogarasi, S. I., Vengrenyuk, Y., Teverovskiy, M., et al. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.02.135 · Cited by 53
Self-citationGenome-wide Association Study of Prostate Cancer Mortality
Penney, K. L., Pyne, S., Schumacher, F. R., Sinnott, J. A., Mucci, L. A., Kraft, P. L., Ma, J., Oh, W. K., Kurth, T., Kantoff, P. W., et al. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0601 · Cited by 60
Chen, H., Larson, P. E. Z., Gordon, J. W., Bok, R., Ferrone, M., Criekinge, M. V., Carvajal, L. E., Cao, P., Pauly, J. M., Kerr, A. B., et al. (2018) · Magnetic Resonance in Medicine · doi:10.1002/mrm.27179 · Cited by 53
Evaluation of 8q24 and 17q Risk Loci and Prostate Cancer Mortality
Penney, K. L., Salinas, C. A., Pomerantz, M. M., Schumacher, F. R., Beckwith, C. A., Lee, G. M., Oh, W. K., Sartor, O. A., Ostrander, E. A., Kurth, T., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2733 · Cited by 52
Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers
Bommi, J. R., Kummari, S., Lakavath, K., Sukumaran, R. A., Panicker, L. R., Marty, J., & Goud, K. Y. (2023) · Biosensors · doi:10.3390/bios13030398 · Cited by 57
Active Surveillance With Selective Radical Treatment for Localized Prostate Cancer
van As, N. J., & Parker, C. C. (2007) · The Cancer Journal · doi:10.1097/ppo.0b013e318156ff65 · Cited by 52
Cai, Q., Yu, P., Besch-Williford, C. L., Smith, C. J., Sieckman, G. L., Hoffman, T. J., & Ma, L. (2012) · The Prostate · doi:10.1002/pros.22630 · Cited by 52
Role of MRI in Minimally Invasive Focal Ablative Therapy for Prostate Cancer
Rosenkrantz, A. B., Scionti, S. M., Mendrinos, S. E., & Taneja, S. S. (2011) · American Journal of Roentgenology · doi:10.2214/ajr.10.5946 · Cited by 52
Guía de la eau para el cáncer de próstata
Heidenreich, A., Aus, G., Bolla, M., Joniau, S., Vsevolod, B. M., Schmid, H. P., & Zattoni, F. (2009) · Actas Urológicas Españolas · doi:10.1016/s0210-4806(09)74110-5 · Cited by 161
Namiki, S., Ishidoya, S., Tochigi, T., Kawamura, S., Kuwahara, M., Terai, A., Yoshimura, K., Numata, I., Satoh, M., Saito, S., et al. (2006) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyl002 · Cited by 51
Xylinas, E. N., Durand, X., Ploussard, G., Campeggi, A., Allory, Y., Vordos, D., Hoznek, A., Abbou, C.-C., TAILLE, A. D. L., & Salomon, L. (2011) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2010.10.012 · Cited by 51
The current status of robot-assisted radical prostatectomy
Prokar Dasgupta, A., & Kirby, R. S. (2008) · Asian Journal of Andrology · doi:10.1038/aja.2008.11 · Cited by 51
Adjuvant androgen deprivation therapy for prostate cancer treated with radiation therapy
Siddiqui, Z. A., & Krauss, D. J. (2018) · Translational Andrology and Urology · doi:10.21037/tau.2018.01.06 · Cited by 54
Targeted therapy of cancer: new roles for pathologists—prostate cancer
Rubin, M. A. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.11 · Cited by 57
Viewpoint: Expanding Prostate Cancer Screening
Catàlona, W. J., Loeb, S., & Han, M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-6-200603210-00012 · Cited by 51
Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy
Asmar, R., Beebe‐Dimmer, J., Korgavkar, K., Keele, G. R., & Cooney, K. A. (2012) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2012.32 · Cited by 50
Stage Migration and Grade Inflation in Prostate Cancer: Will Rogers Meets Garrison Keillor
Thompson, I. M., Canby‐Hagino, E., & Lucia, M. S. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji286 · Cited by 50
Radical prostatectomy versus watchful waiting for prostate cancer
Hegarty, J. M., Beirne, P. V., Walsh, E., Comber, H., Fitzgerald, T., & Kazer, M. W. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006590.pub2 · Cited by 49
Management of sexual problems in cancer patients and survivors
Varela, V. S., Zhou, E. S., & Bober, S. L. (2013) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2013.10.009 · Cited by 55
What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models
Gulati, R., Wever, E. M., Tsodikov, A., Penson, D. F., Inoue, L. Y. T., Katcher, J., Lee, S., Heijnsdijk, E. A. M., Draisma, G., de Koning, H. J., et al. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0718 · Cited by 49
Hamdy, F. C., Donovan, J., Lane, J. A., Mason, M. D., Metcalfe, C., Holding, P., Wade, J., Noble, S., Garfield, K., Young, G., et al. (2020) · Health Technology Assessment · doi:10.3310/hta24370 · Cited by 51
Complications of Open Radical Retropubic Prostatectomy in Potential Candidates for Active Monitoring
Loeb, S., Roehl, K. A., Helfand, B. T., & Catàlona, W. J. (2008) · Urology · doi:10.1016/j.urology.2007.12.016 · Cited by 48
Trans-rectal ultrasound-coupled near-infrared optical tomography of the prostate, Part I: Simulation
Xu, G., Piao, D. D., Musgrove, C. H., Bunting, C. F., & Dehghani, H. (2008) · Optics Express · doi:10.1364/oe.16.017484 · Cited by 48
Pierorazio, P. M., Spencer, B. A., McCann, T. R., McKiernan, J. M., & Benson, M. C. (2007) · Urology · doi:10.1016/j.urology.2007.06.639 · Cited by 47
Holmberg, L., Bill‐Axelson, A., Steineck, G., Garmo, H., Palmgren, J., Johansson, E., Adami, H., & Johansson, J.-E. (2012) · JNCI Monographs · doi:10.1093/jncimonographs/lgs025 · Cited by 48
Self-citationDecision Making in Prostate-Specific Antigen Screening
Han, P. K. J., Coates, R. J., Uhler, R. J., & Breen, N. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.12.006 · Cited by 51
The value of an additional hypoechoic lesion‐directed biopsy core for detecting prostate cancer
Gosselaar, C., Roobol, M. J., Roemeling, S., Wolters, T., van Leenders, G. J. L. H., & Schröder, F. H. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07309.x · Cited by 46
Prostate cancer: epidemiology, screening, and biomarkers.
Chodak, G. W. (2006) · Europe PMC (PubMed Central) · Cited by 46
Gleason score 7 screen‐detected prostate cancers initially managed expectantly: outcomes in 50 men
van den Bergh, R. C. N., Roemeling, S., Roobol, M. J., Aus, G., Hugosson, J., Rannikko, A. S., Tammela, T. L. J., Bangma, C. H., & Schröder, F. H. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.08281.x · Cited by 45
Zu, K., Martin, N. E., Fiorentino, M., Flavin, R., Lis, R. T., Sinnott, J. A., Finn, S. P., Penney, K. L., Ma, J., Fazli, L., et al. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0349 · Cited by 45
Epidemiology, Pathology and Pathogenesis
Reid, S., & Hamdy, F. C. (2008) · Springer eBooks · doi:10.1007/978-1-84628-738-1_25 · Cited by 45
Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial
Johnston, T. J., Shaw, G. L., Lamb, A. D. G., Parashar, D., Greenberg, D. C., Xiong, T., Edwards, A. L., Gnanapragasam, V. J., Holding, P., Herbert, P., et al. (2016) · European Urology · doi:10.1016/j.eururo.2016.09.040 · Cited by 45
Jhavar, S. G., Bartlett, J., Kovács, G., Corbishley, C. M., Dearnaley, D. P., Eeles, R. A., Khoo, V. S., Huddart, R. A., Horwich, A., Thompson, A. C., et al. (2008) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2008.47 · Cited by 45
Tewari, A. K., Raman, J. D., Chang, P., Rao, S., Divine, G., & Menon, M. (2006) · Urology · doi:10.1016/j.urology.2006.08.1059 · Cited by 43
Shear wave elastography assessment in the prostate: an intraobserver reproducibility study
Woo, S., Kim, S. Y., Lee, M. S., Cho, J. Y., & Kim, S. H. (2014) · Clinical Imaging · doi:10.1016/j.clinimag.2014.11.013 · Cited by 44
Namiki, S., Kwan, L. C., Kagawa‐Singer, M., Tochigi, T., Ioritani, N., Terai, A., Arai, Y., & Litwin, M. S. (2007) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4501013 · Cited by 47
Pinkawa, M., Fischedick, K., Gagel, B., Piroth, M. D., Asadpour, B., Klotz, J., Borchers, H., Jakse, G., & Eble, M. J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-296 · Cited by 44
Active surveillance and radical therapy in prostate cancer: can focal therapy offer the middle way?
Ahmed, H. U., & Emberton, M. (2008) · World Journal of Urology · doi:10.1007/s00345-008-0317-5 · Cited by 43
Prostate cancer in the elderly
Hans Heinzer, A., & Steuber, T. P. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.07.015 · Cited by 43
Quality of Life After Therapy for Localized Prostate Cancer
Penson, D. F. (2007) · The Cancer Journal · doi:10.1097/ppo.0b013e3181570121 · Cited by 43
Prostate cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Horwich, A., Parker, C. C., & Kataja, V. V. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp135 · Cited by 43
Ying, A., Xu, R., & Murphy, J. D. (2018) · Statistics in Medicine · doi:10.1002/sim.8071 · Cited by 43
Balancing the harms and benefits of early detection of prostate cancer
van Leeuwen, P. J., Connolly, D., Tammela, T. L. J., Auvinen, A. P., Ries Kranse, C., Roobol, M. J., Schröder, F. H., & Gavin, A. (2010) · Cancer · doi:10.1002/cncr.25474 · Cited by 44
Cesaretti, J. A., Kao, J., Stone, N. N., & Stock, R. G. (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07016.x · Cited by 42
The central role of osteoblasts in the metastasis of prostate cancer
Choueiri, M., Tu, S., Yu‐Lee, L., & Lin, S.-H. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9034-y · Cited by 43
Renard‐Penna, R., Morgan Rouprêt, A., Compérat, É., Ayed, A., Coudert, M., Mozer, P., Xylinas, E. N., Bitker, M., & Greniér, P. (2011) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2011.02.017 · Cited by 41
A system for MRI‐guided transperineal delivery of needles to the prostate for focal therapy
Cepek, J., Chronik, B. A., Lindner, U., Trachtenberg, J., Davidson, S. R. H., Bax, J. S., & Fenster, A. (2013) · Medical Physics · doi:10.1118/1.4773043 · Cited by 42
Abdollah, F., Sun, M., Schmitges, J., Thuret, R., Bianchi, M., Shariat, S. F., Briganti, A., Claudio Jeldres, A., Perrotte, P., Montorsi, F., et al. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.03.005 · Cited by 42
Metadata
- Authors
- Bill-Axelson, A., Holmberg, L., Ruutu, M., Häggman, M., Andersson, S.-O., Bratell, S., Spångberg, A., Busch, C., Nordling, S., Garmo, H., Palmgren, J., Adami, H.-O., Norlén, B. J., & Johansson, J.-E.
- Affiliations
- University of Helsinki (FI)
- Linköping University Hospital (SE)
- Uppsala University Hospital (SE)
- Karolinska Institutet (SE)
- Harvard University (US)
- Örebro University Hospital (SE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-05-12
- Volume
- 352
- Issue
- 19
- Pages
- 1977-1984
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4233182856
- Cited by
- 1,111
- References
- 11
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 18 · 2022: 5 · 2021: 7 · 2020: 10 · 2019: 23 · 2018: 21 · 2017: 20 · 2016: 24 · 2015: 35 · 2014: 35 · 2013: 50 · 2012: 68
- FWCI
- 120.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- radical prostatectomy, expectant management, early-stage prostate cancer, prostate cancer mortality, distant metastasis, local tumor progression, all-cause mortality, long-term follow-up, surgical versus conservative treatment
- MeSH terms
- Aged, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasm Metastasis, Prostatectomy, Prostatic Neoplasms, Incidence, Proportional Hazards Models, Survival Analysis, Disease Progression, Antineoplastic Agents, Hormonal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.